BUSULPHAN Side Effects

5869072-1 | Epistaxis
on Sep 02, 2008 Female patient from ITALY , 85 years of age, weighting 136.7 lb, was diagnosed with hypertension and was treated with Busulphan (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis. Busulphan dosage: 2mg Per Day. During the same period patient was treated with WARFARIN SODIUM (2.5mg Per Day) (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (12.5mg Three Times Per Week) (View Furosemide Review and Furosemide Label ), TELMISARTAN (80mg Alternate Days) (View Telmisartan Review and Telmisartan Label ), HYDROCHLOROTHIAZIDE (12.5mg Alternate Days) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5851124-3 | Aplasia, Bacteraemia, Bone Marrow Failure, Dyspnoea Exertional, Iron Deficiency Anaemia, Neutropenia, Phlebitis, Self Injurious Behaviour
Patient was taking Busulphan (View Usage). Patient had the following side effects: aplasia, bacteraemia, bone marrow failure, dyspnoea exertional, iron deficiency anaemia, neutropenia, phlebitis, self injurious behaviour on Jun 05, 2008 from FRANCE Additional patient health information: Male patient , 32 years of age, . Busulphan dosage: 5tab Per Day. Patient was hospitalized.

5700318-6 | Abdominal Pain Upper, Ascites, Haematemesis, Haematochezia, Hepatic Fibrosis, Jaundice, Oesophageal Varices Haemorrhage, Thrombocytopenia, Vanishing Bile Duct Syndrome
Adverse event was reported on Apr 04, 2008 by a Male patient taking Busulphan (View Usage) (Dosage: ) was diagnosed with neuroblastoma (What is neuroblastoma?) and. Location: JAPAN , child 4 years of age, After Busulphan was administered, patient had the following side effects: abdominal pain upper, ascites, haematemesis, haematochezia, hepatic fibrosis, jaundice (What is jaundice?), oesophageal varices haemorrhage, thrombocytopenia, vanishing bile duct syndrome. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

5244207-2 | Acute Graft Versus Host Disease In Skin, Cerebral Toxoplasmosis, Leukaemia Recurrent
on Feb 14, 2007 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with graft versus host disease and was treated with Busulphan (View Usage). Patient experienced the following unwanted or unexpected effects: acute graft versus host disease in skin, cerebral toxoplasmosis, leukaemia recurrent. Busulphan dosage: . During the same period patient was treated with CAMPATH (View Campath Review and Campath Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ), TRIMETOPRIM (View Trimetoprim Review and Trimetoprim Label ).


4823635-0 | Anaemia Haemolytic Autoimmune, Blood Bilirubin Increased, Haemoglobin Decreased, Jaundice, Marrow Hyperplasia, Platelet Count Decreased
on Apr 07, 2005 Male patient from UNITED KINGDOM , 40 years of age, was treated with Busulphan (View Usage). Patient had the following side effects: anaemia haemolytic autoimmune, blood bilirubin increased, haemoglobin decreased, jaundice (What is jaundice?), marrow hyperplasia, platelet count decreased. Busulphan dosage: . During the same period patient was treated with MABCAMPATH (20mg Five Times Per Day) (View Mabcampath Review and Mabcampath Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ).

4732517-4 | Bronchopneumonia, Cardiac Arrest, Decreased Appetite, Fatigue, Lung Abscess, Micturition Urgency, Nausea, Quadriplegia, Radiation Myelopathy
Patient was taking Busulphan (View Usage). After Busulphan was administered, patient had the following side effects: bronchopneumonia, cardiac arrest (What is cardiac arrest?), decreased appetite, fatigue, lung abscess, micturition urgency, nausea (What is nausea?), quadriplegia, radiation myelopathy on Jan 08, 2003 from UNITED KINGDOM Additional patient health information: Male patient , 19 years of age, weighting 152.1 lb, was diagnosed with ewing's sarcoma and. Busulphan dosage: 1100mgm2 Cumulative Dose. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ). Patient was hospitalized and became disabled.

4666096-7 | Febrile Neutropenia, Gastrointestinal Toxicity, Sepsis
Adverse event was reported on Mar 22, 2005 by a Male patient taking Busulphan (View Usage) (Dosage: 4mgk Per Day) . Location: , child 3 years of age, Patient experienced the following unwanted or unexpected effects: febrile neutropenia, gastrointestinal toxicity, sepsis (What is sepsis?). During the same period patient was treated with MELPHALAN (140mgm2 Per Day) (View Melphalan Review and Melphalan Label ), NEUPOGEN (12ugk Twice Per Day) (View Neupogen Review and Neupogen Label ).

4666095-5 | Febrile Neutropenia, Gastrointestinal Toxicity
on Mar 22, 2005 Male patient from , child 4 years of age, was treated with Busulphan (View Usage). Patient had the following side effects: febrile neutropenia, gastrointestinal toxicity. Busulphan dosage: 4mgk Per Day. During the same period patient was treated with MELPHALAN (140mgm2 Per Day) (View Melphalan Review and Melphalan Label ), TOPOTECAN (2mgm2 Per Day) (View Topotecan Review and Topotecan Label ), NEUPOGEN (12ugk Twice Per Day) (View Neupogen Review and Neupogen Label ).

4666094-3 | Febrile Neutropenia, Gastrointestinal Toxicity, Varicella
on Mar 22, 2005 Female patient from , child 2 years of age, was treated with Busulphan (View Usage). After Busulphan was administered, patient had the following side effects: febrile neutropenia, gastrointestinal toxicity, varicella. Busulphan dosage: 4mgk Per Day. During the same period patient was treated with MELPHALAN (140mgm2 Per Day) (View Melphalan Review and Melphalan Label ), TOPOTECAN (2mgm2 Per Day) (View Topotecan Review and Topotecan Label ), NEUPOGEN (12ugk Twice Per Day) (View Neupogen Review and Neupogen Label ).

4666093-1 | Febrile Neutropenia, Gastrointestinal Toxicity
Patient was taking Busulphan (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, gastrointestinal toxicity on Mar 22, 2005 from Additional patient health information: Male patient , child 1 years of age, . Busulphan dosage: 4mgk Per Day. During the same period patient was treated with MELPHALAN (140mgm2 Per Day) (View Melphalan Review and Melphalan Label ), THIOTEPA (250mgm2 Per Day) (View Thiotepa Review and Thiotepa Label ), NEUPOGEN (12ugk Twice Per Day) (View Neupogen Review and Neupogen Label ).

4634120-3 | Anaemia Haemolytic Autoimmune, Blood Bilirubin Increased, Haemoglobin Decreased, Jaundice, Marrow Hyperplasia, Platelet Count Decreased
Adverse event was reported on Apr 07, 2005 by a Male patient taking Busulphan (View Usage) (Dosage: ) . Location: , 48 years of age, Patient had the following side effects: anaemia haemolytic autoimmune, blood bilirubin increased, haemoglobin decreased, jaundice (What is jaundice?), marrow hyperplasia, platelet count decreased. During the same period patient was treated with MABCAMPATH (20mg Five Times Per Day) (View Mabcampath Review and Mabcampath Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ).